Evidence from 2 randomized clinical trials suggests that long-term intraocular pressure variability does not add substantial explanatory power to a prediction model determining which individuals with ...

AAO: Microstent Cuts Intraocular Pressure in Glaucoma For patients with mild-to-moderate open-angle glaucoma, implantation of a nickel titanium microstent (Hydrus Microstent) is associated with ...

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...

Glaucoma is a common ocular disease in which the optic nerve malfunctions due to the increased intraocular pressure (IOP) caused by drainage canal blocking in the eye. This condition narrows the ...

Glaucoma, which affects an estimated 57 million people worldwide, is an eye condition caused by too much pressure around the eye, which can damage the optical nerve and lead to irreversible blindness.

Sleeping without pillows may help lower high internal eye pressure, the build-up of which causes optic nerve damage and glaucoma—the leading cause of irreversible blindness worldwide—in people with ...

Fluctuations in blood pressure over an extended period, along with their interaction with mean blood pressure or intraocular pressure, are associated with a more rapid visual field progression in ...

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, will present this week the results of ...